{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:16:14Z","timestamp":1792548974504,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007938.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000}}],"reference-count":205,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007938.pub4","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T05:07:21Z","timestamp":1496984841000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":216,"title":["Gabapentin for chronic neuropathic pain in adults"],"prefix":"10.1002","volume":"2020","author":[{"given":"Philip J","family":"Wiffen","sequence":"first","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Frances","family":"Bell","sequence":"additional","affiliation":[{"name":"Haukeland University Hospital; Regional Centre of Excellence in Palliative Care; Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew SC","family":"Rice","sequence":"additional","affiliation":[{"name":"Imperial College London; Pain Research, Department of Surgery and Cancer, Faculty of Medicine; London UK SW10 9NH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Rudolf","family":"T\u00f6lle","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Neurology, Klinikum Rechts der Isar; M\u00f6hlstrasse 28 Munich Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor","family":"Phillips","sequence":"additional","affiliation":[{"name":"University of Oxford; Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); Churchill Hospital Oxford UK OX3 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/j.pain.0000000000000554","article-title":"A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component","volume":"157","author":"Atkinson","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0003|cit2","unstructured":"Trial summary - Parke Davis\/Pfizer 945-210 Unpublished report"},{"issue":"21","key":"10.1002\/14651858.CD007938.pub4-BIB0002|cit3","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1526-4637.2011.01139.x","article-title":"Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin","volume":"12","author":"Backonja","year":"2011","journal-title":"Pain Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub4-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/rapm.2002.35169","article-title":"Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study","volume":"27","author":"Bone","year":"2002","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"14","key":"10.1002\/14651858.CD007938.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group","volume":"22","author":"Caraceni","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD007938.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5414\/CPP44358","article-title":"Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial - the GONIP Trial","volume":"44","author":"Chandra","year":"2006","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"h1748","DOI":"10.1136\/bmj.h1748","article-title":"Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study","volume":"350","author":"Cohen","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0009|cit9","unstructured":"Protocol A9451008. A 15 week, randomized, double-blind, placebo-controlled, parallel-group, multi-center study of Neurontin (gabapentin) for efficacy and quality of life in patients with painful diabetic peripheral neuropathy PhrmaWebSynopsis - Final"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0010|cit10","unstructured":"Protocol 945-224. A double-blind placebo-controlled trial with 3 doses of gabapentin for treatment of painful diabetic peripheral neuropathy. May 29, 1998 through September 7, 1999 Unpublished"},{"issue":"13","key":"10.1002\/14651858.CD007938.pub4-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"9697","key":"10.1002\/14651858.CD007938.pub4-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/s0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0013|cit13","article-title":"The efficacy and safety of gabapentin in postherpetic neuralgia","volume":"2","author":"Gong","year":"2008","journal-title":"Chinese Journal of Pain Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pain.2007.12.011","article-title":"Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study","volume":"138","author":"Gordh","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jnnp.66.2.251","article-title":"Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial","volume":"66","author":"Gorson","year":"1999","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD007938.pub4-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s00415-004-0529-6","article-title":"A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies","volume":"251","author":"Hahn","year":"2004","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/pme.12227","article-title":"A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate responders","volume":"14","author":"Harden","year":"2013","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/AJP.0b013e3181934276","article-title":"Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial","volume":"25","author":"Irving","year":"2009","journal-title":"Clinical Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/AJP.0b013e318192bf87","article-title":"Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia","volume":"25","author":"Jensen","year":"2009","journal-title":"Clinical Journal of Pain"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/01.BRS.0000112068.16108.3A","article-title":"Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury","volume":"29","author":"Levendoglu","year":"2004","journal-title":"Spine"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1049909111412539","article-title":"A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study","volume":"29","author":"Mishra","year":"2012","journal-title":"American Journal of Hospice and Palliative Care"},{"issue":"16","key":"10.1002\/14651858.CD007938.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","article-title":"Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain","volume":"159","author":"Morello","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0023|cit23","unstructured":"A Phase II, double-blind, randomized, placebo-controlled non-inferiority trial of EpiCept\u2122 NP-1 topical cream (2% ketamine\/4% amitriptyline) vs. oral gabapentin in postherpetic neuralgia (PHN) clinicaltrials.gov\/ct2\/show\/NCT00475904"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0024|cit24","unstructured":"A study of lidocaine patch 5% alone, gabapentin alone, and lidocaine patch 5% and gabapentin in combination for the relief of pain in patients with diverse peripheral neuropathic pain conditions clinicaltrials.gov\/ct2\/show\/NCT00904202"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0025|cit25","unstructured":"Clinical trial results summary: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study of lidocaine patch 5% alone, gabapentin alone, and lidocaine patch 5% and gabapentin in combination for the relief of pain in patients with diverse peripheral neuropathic pain conditions endo.com\/home\/search?k=EN3220-009"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0002-9343(00)00398-3","article-title":"Gabapentin therapy for diabetic neuropathic pain","volume":"108","author":"Perez","year":"2000","journal-title":"Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/cncr.23008","article-title":"Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)","volume":"110","author":"Rao","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub4-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/papr.12014","article-title":"A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy","volume":"13","author":"Rauck","year":"2013","journal-title":"Pain Practice"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/ALN.0b013e3182a10fbf","article-title":"Intrathecal gabapentin to treat chronic intractable noncancer pain","volume":"119","author":"Rauck","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0031|cit30","unstructured":"Study detail and analysis, Parke-Davis 945-295 Unpublished Report No. RR-430-00124 2000"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0030|cit31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.apmr.2007.07.038","article-title":"Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury","volume":"88","author":"Rintala","year":"2007","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0033|cit33","unstructured":"Detailed summary, study No.4, Parke-Davis 945-211 Unpublished Report No. RR-995-00070 1998"},{"issue":"21","key":"10.1002\/14651858.CD007938.pub4-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.diabres.2012.03.010","article-title":"A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial","volume":"97","author":"Sandercock","year":"2012","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.2337\/dc08-1450","article-title":"Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial","volume":"32","author":"Sandercock","year":"2009","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD007938.pub4-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/pme.12791","article-title":"Relationships among pain quality, pain impact, and overall improvement in patients with postherpetic neuralgia treated with gastroretentive gabapentin","volume":"16","author":"Freeman","year":"2015","journal-title":"Pain Medicine (Malden, Mass.)"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12955-016-0456-0","article-title":"Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin","volume":"14","author":"Mehta","year":"2016","journal-title":"Health and Quality of Life Outcomes"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/AJP.0b013e318258993e","article-title":"Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN)","volume":"29","author":"Sang","year":"2013","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0040|cit40","unstructured":"Parke Davis\/Pfizer 945-430-306 Unpublished 2000"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0304-3959(02)00255-5","article-title":"Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial","volume":"99","author":"Serpell","year":"2002","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00131402-200112000-00002","article-title":"Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy","volume":"3","author":"Simpson","year":"2001","journal-title":"Journal of Clinical Neuromuscular Disease"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub4-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1682\/JRRD.2005.05.0082","article-title":"Efficacy of gabapentin in treating chronic phantom limb and residual limb pain","volume":"42","author":"Smith","year":"2005","journal-title":"Journal of Rehabilitation Research and Development"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10790268.2002.11753609","article-title":"Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial","volume":"25","author":"Tai","year":"2002","journal-title":"Journal of Spinal Cord Medicine"},{"issue":"10","key":"10.1002\/14651858.CD007938.pub4-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/pme.12791","article-title":"Relationships among pain quality, pain impact, and overall improvement in patients with postherpetic neuralgia treated with gastroretentive gabapentin","volume":"16","author":"Freeman","year":"2015","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12955-016-0456-0","article-title":"Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin","volume":"14","author":"Mehta","year":"2016","journal-title":"Health and Quality of Life Outcomes"},{"issue":"11","key":"10.1002\/14651858.CD007938.pub4-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2165\/11539520-000000000-00000","article-title":"Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study","volume":"30","author":"Wallace","year":"2010","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/pm\/pnv072","article-title":"Impact of data imputation methodology on pain assessment over 24 hours in a randomized, placebo-controlled study of gabapentin enacarbil in patients with neuropathic pain associated with postherpetic neuralgia","volume":"17","author":"Calkins","year":"2016","journal-title":"Pain Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub4-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jpain.2013.01.768","article-title":"A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748)","volume":"14","author":"Zhang","year":"2013","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00540-010-0913-6","article-title":"Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine","volume":"24","author":"Arai","year":"2010","journal-title":"Journal of Anesthesia"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1212\/01.wnl.0000168259.94991.8a","article-title":"A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster","volume":"65","author":"Berry","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0885-3924(00)00181-0","article-title":"Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study","volume":"20","author":"Dallocchio","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"issue":"20","key":"10.1002\/14651858.CD007938.pub4-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3969\/j.issn.1000-8179.20141212","article-title":"Assessment of transdermal fentanyl combined with gabapentin for malignant neuropathic pain treatment","volume":"41","author":"Ding","year":"2014","journal-title":"Chinese Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pain.2008.12.022","article-title":"A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster","volume":"142","author":"Dworkin","year":"2009","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD007938.pub4-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pain.2008.07.013","article-title":"Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies","volume":"14","author":"Ho","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0056|cit56","first-page":"73","article-title":"Starting dose of gabapentin for patients with post-herpetic neuralgia--a dose-response study","volume":"43","author":"Jean","year":"2005","journal-title":"Acta Anaesthesiologica Taiwan"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.2176\/nmc.50.1070","article-title":"Efficacy of gabapentin for radiculopathy caused by lumbar spinal stenosis and lumbar disk hernia","volume":"50","author":"Kasimcan","year":"2010","journal-title":"Neurologia Medico Chirurgica (Tokyo)"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpainsymman.2006.11.013","article-title":"Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial","volume":"34","author":"Keskinbora","year":"2007","journal-title":"Journal of Pain Symptom Management"},{"issue":"1-2","key":"10.1002\/14651858.CD007938.pub4-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pain.2006.08.028","article-title":"Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial","volume":"127","author":"Kimos","year":"2007","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/j.1464-5491.2010.03054.x","article-title":"Comparison of the efficacy and safety of tramadol\/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy","volume":"27","author":"Ko","year":"2010","journal-title":"Diabetes Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1163\/156856901753420945","article-title":"Does gabapentin have an analgesic effect on background, movement and referred pain? A randomised, double-blind, placebo controlled study","volume":"13","author":"McCleane","year":"2001","journal-title":"The Pain Clinic"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0062|cit62","unstructured":"A study to compare safety and efficacy of tramadol hydrochloride\/acetaminophen with gabapentin in participants with diabetic neuropathy clinicaltrials.gov\/ct2\/show\/NCT00634543"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0063|cit63","unstructured":"Neuropathic pain treatment using F0434 vs. gabapentin in patients with chronic distal diabetic polyneuropathy: a randomized, controlled, double-blind study clinicaltrials.gov\/ct2\/show\/NCT01263132"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0064|cit64","unstructured":"Treatment of complex regional pain syndrome with once daily gastric-retentive gabapentin (Gralise) clinicaltrials.gov\/ct2\/show\/NCT01623271"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00000542-200611000-00023","article-title":"A randomized study of the effects of gabapentin on postamputation pain","volume":"105","author":"Nikolajsen","year":"2006","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub4-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/00000539-200212000-00046","article-title":"Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double-blinded, placebo-controlled, crossover study","volume":"95","author":"Pandey","year":"2002","journal-title":"Anesthesia and Analgesia"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1213\/01.ANE.0000152186.89020.36","article-title":"The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre syndrome patients in the intensive care unit","volume":"101","author":"Pandey","year":"2005","journal-title":"Anesthesia and Analgesia"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.1526-4637.2008.00515.x","article-title":"Facial pain: a possible therapy with stellate ganglion block","volume":"9","author":"Salvaggio","year":"2008","journal-title":"Pain Medicine"},{"issue":"21-22","key":"10.1002\/14651858.CD007938.pub4-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00508-005-0464-2","article-title":"Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study","volume":"117","author":"Sator-Katzenschlager","year":"2005","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4065\/mcp.2010.0681","article-title":"Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison","volume":"86","author":"Tanenberg","year":"2011","journal-title":"Mayo Clinic proceedings"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2377-4-13","article-title":"Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]","volume":"4","author":"Vusse","year":"2004","journal-title":"BMC Neurology"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/01.brs.0000261029.29170.e6","article-title":"The efficiency of gabapentin therapy in patients with lumbar spinal stenosis","volume":"32","author":"Yaksi","year":"2007","journal-title":"Spine"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1526-4637.2009.00615.x","article-title":"N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain","volume":"10","author":"Yelland","year":"2009","journal-title":"Pain Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1163\/156856903767650718","article-title":"The effectiveness of gabapentin in patients with chronic radiculopathy","volume":"15","author":"Yildirim","year":"2003","journal-title":"The Pain Clinic"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1472-6882-9-31","article-title":"Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial","volume":"9","author":"Fleckenstein","year":"2009","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0076|cit76","unstructured":"Vasheghani M (contact person) Effect of gabapentin on heart rate variability in diabetic painful peripheral neuropathy: a double blinded randomized clinical trial apps.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT201212019014N14"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0077|cit77","unstructured":"A study of the efficacy of gabapentin in neuropathic pain patients as measured by quantitative sensory testing clinicaltrials.gov\/ct2\/show\/NCT00674687"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ijcard.2012.11.048","article-title":"Random error in cardiovascular meta-analyses: how common are false positive and false negative results?","volume":"168","author":"AlBalawi","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(11)70281-2","article-title":"Chronic pain: genes, plasticity, and phenotypes","volume":"11","author":"Baron","year":"2012","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1533-2500.2008.00244.x","article-title":"Clinical and economic characteristics of patients with painful neuropathic disorders in Germany","volume":"9","author":"Berger","year":"2009","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2377-12-8","article-title":"Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study","volume":"12","author":"Berger","year":"2012","journal-title":"BMC Neurology"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.pain.2014.09.003","article-title":"The effect of a combination of gabapentin and donepezil in an experimental pain model in health volunteers: results of a randomised controlled trial","volume":"155","author":"Boyle","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"631756","DOI":"10.1155\/2014\/631756","article-title":"Gabapentin in acute postoperative pain management","volume":"2014","author":"Chang","year":"2014","journal-title":"Biomed Research International"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008943.pub2","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","author":"Chaparro","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11606-008-0877-5","article-title":"Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials","volume":"24","author":"Chou","year":"2009","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012188.pub2","article-title":"Gabapentin for fibromyalgia pain in adults","author":"Cooper","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD007938.pub4-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010958.pub2","article-title":"Topical lidocaine for neuropathic pain in adults","author":"Derry","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD007938.pub4-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011605.pub2","article-title":"Fentanyl for neuropathic pain in adults","author":"Derry","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub4","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"11","key":"10.1002\/14651858.CD007938.pub4-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0103|cit103","unstructured":"Electronic Medicines Compendium emc.medicines.org.uk\/"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0104|cit104","unstructured":"Effective Practice Organisation of Care (EPOC) 23. Worksheets for preparing a Summary of Findings using GRADE. Resources for review authors Oslo: Norwegian Knowledge Centre for the Health Services. Available at: epoc.cochrane.org\/epoc-specific-resources-review-authors"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1073\/pnas.1618569114","article-title":"Meta-assessment of bias in science","volume":"114","author":"Fanelli","year":"2017","journal-title":"PNAS"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/j.1532-2149.2012.00282.x","article-title":"Neuropathic pain needs systematic classification","volume":"17","author":"Finnerup","year":"2013","journal-title":"European Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub3","article-title":"Oxycodone for neuropathic pain in adults","author":"Gaskell","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence--inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Cinical Epidemiology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2296-14-28","article-title":"An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population","volume":"14","author":"Hall","year":"2013","journal-title":"BMC Family Practice"},{"issue":"1-2","key":"10.1002\/14651858.CD007938.pub4-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin - a meta-analysis of randomized controlled trials","volume":"145","author":"Ha\u00fcser","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cpt.19","article-title":"Individualized pharmacological treatment of neuropathic pain","volume":"97","author":"Helfert","year":"2015","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0122|cit122","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status 3 and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0125|cit125","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"issue":"8","key":"10.1002\/14651858.CD007938.pub4-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1526-4637.2012.01427.x.","article-title":"Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgia","volume":"13","author":"Jensen","year":"2012","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"issue":"5-6","key":"10.1002\/14651858.CD007938.pub4-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub4-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archinte.1996.00440060089011","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD007938.pub4-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJMp0808659","article-title":"The Neurontin legacy - marketing through misinformation and manipulation","volume":"360","author":"Landefeld","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0133|cit133","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub2","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0134|cit134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7012","key":"10.1002\/14651858.CD007938.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0304-3959(95)00116-6","article-title":"Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems","volume":"64","author":"McQuay","year":"1996","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0137|cit137","article-title":"An evidence-based resource for pain relief","volume-title":"An evidence-based resource for pain relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0138|cit138","article-title":"Chronic Pain","volume-title":"Health Care Needs Assessment: The Epidemiologically Based Needs Assessment Reviews: Third Series","author":"McQuay","year":"2007"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pain.2008.01.014","article-title":"Enriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic pain","volume":"135","author":"McQuay","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0140|cit140","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0141|cit141","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain--establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pain.2010.02.032","article-title":"Topical review: chronic low back pain analgesic studies - a methodological minefield","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub4-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD007938.pub4-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.pain.2013.03.024","article-title":"What works for whom? Determining the efficacy and harm of treatments for pain","volume":"154","author":"Moore","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0153|cit153","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0156|cit156","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"10","key":"10.1002\/14651858.CD007938.pub4-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010902.pub2","article-title":"Oral nonsteroidal anti-inflammatory drugs for neuropathic pain","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0158|cit158","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub3","article-title":"Amitriptyline for neuropathic pain in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD007938.pub4-BIB0159|cit159","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","article-title":"Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society","volume":"19","author":"Moulin","year":"2014","journal-title":"Pain Research & Management"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0161|cit161","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jclinepi.2017.02.010","article-title":"Simple randomization did not protect against bias in smaller trials","volume":"84","author":"Nguyen","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0162|cit162","unstructured":"National Institute for Health and Care Excellence (NICE) Neuropathic pain - pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings, 2013 www.nice.org.uk\/guidance\/cg173"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment: outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0165|cit165","unstructured":"Cochrane Pain Palliative and Supportive Care Group PaPaS Author and Referee Guidance papas.cochrane.org\/papas-documents"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0166|cit166","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.amjopharm.2011.04.007","article-title":"Anorgasmia with gabapentin may be common in older patients","volume":"9","author":"Perloff","year":"2011","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0167|cit167","unstructured":"Perry T Neurontin - expert opinion on efficacy and effectiveness for pain industrydocumentslibrary.ucsf.edu\/drug\/docs\/#id=fhhw0217"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0168|cit168","doi-asserted-by":"publisher","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials","volume":"5","author":"Phillips","year":"2010","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2377-9-6","article-title":"Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain","volume":"9","author":"Quilici","year":"2009","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/JEP.S124391","article-title":"Review about gabapentin misuse, interactions, contraindications and side effects","volume":"9","author":"Quintero","year":"2017","journal-title":"Journal of Experimental Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0171|cit171","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jpainsymman.2012.07.011","article-title":"Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies","volume":"46","author":"Rauck","year":"2013","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0173|cit173","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"h2463","DOI":"10.1136\/bmj.h2463","article-title":"The knowledge system underpinning healthcare is not fit for purpose and must change","volume":"350","author":"Roberts","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0175|cit175","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0176|cit176","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0177|cit177","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0178|cit178","unstructured":"Scottish Intercollegiate Guidelines Network SIGN Guideline 136: Management of Chronic Pain sign.ac.uk\/guidelines\/fulltext\/136\/contents.html 2013"},{"issue":"7","key":"10.1002\/14651858.CD007938.pub4-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.seizure.2003.12.006","article-title":"Epilepsy and erectile dysfunction: a review","volume":"13","author":"Smaldone","year":"2004","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0180|cit180","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1002\/art.37962","article-title":"Neuropathic features of joint pain: a community-based study","volume":"April 1","author":"Soni","year":"2013","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub4-BIB0181|cit181","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011604.pub2","article-title":"Hydromorphone for neuropathic pain in adults","author":"Stannard","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007938.pub4-BIB0182|cit182","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD007938.pub4-BIB0183|cit183","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008183.pub2","article-title":"Single dose oral gabapentin for established acute postoperative pain in adults","author":"Straube","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"10","key":"10.1002\/14651858.CD007938.pub4-BIB0185|cit185","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"18","key":"10.1002\/14651858.CD007938.pub4-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0188|cit188","doi-asserted-by":"publisher","first-page":"e59202","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane Reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0189|cit189","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00228-008-0523-5","article-title":"Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature","volume":"64","author":"Tzellos","year":"2008","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD007938.pub4-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2710.2009.01144.x","article-title":"Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis","volume":"35","author":"Tzellos","year":"2010","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD007938.pub4-BIB0191|cit191","first-page":"1003","article-title":"Pharmacological Therapy for Neuropathic Pain","volume-title":"Wall and Melzack's Textbook of Pain","author":"T\u00f6lle","year":"2013"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0192|cit192","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Hecke","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0193|cit193","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"Hoek","year":"2009","journal-title":"Vaccine"},{"issue":"20","key":"10.1002\/14651858.CD007938.pub4-BIB0194|cit194","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1056\/NEJMsa0906126","article-title":"Outcome reporting in industry-sponsored trials of gabapentin for off-label use","volume":"361","author":"Vedula","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0195|cit195","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype\u00a0to reveal neural mechanisms","volume":"73","author":"Hehn","year":"2012","journal-title":"Neuron"},{"issue":"9859","key":"10.1002\/14651858.CD007938.pub4-BIB0196|cit196","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0197|cit197","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/09546634.2016.1163315","article-title":"Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials","volume":"28","author":"Wang","year":"2017","journal-title":"Journal of Dermatology Treatment"},{"issue":"1","key":"10.1002\/14651858.CD007938.pub4-BIB0198|cit198","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub3","article-title":"Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD007938.pub4-BIB0199|cit199","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD007938.pub4-BIB0200|cit200","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011603.pub2","article-title":"Buprenorphine for neuropathic pain in adults","author":"Wiffen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007938.pub4-BIB0201|cit201","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012227.pub2","article-title":"Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults","author":"Wiffen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0202|cit202","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007938.pub4-BIB0203|cit203","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0204|cit204","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub2","article-title":"Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007938.pub4-BIB0205|cit205","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005452","article-title":"Gabapentin for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007938.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T17:17:28Z","timestamp":1636132648000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007938.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":205,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007938.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]}}}